News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
501,312 Results
Type
Article (37139)
Company Profile (322)
Press Release (463851)
Multimedia
Podcasts (78)
Webinars (10)
Section
Business (142232)
Career Advice (1390)
Deals (27618)
Drug Delivery (105)
Drug Development (73129)
Employer Resources (116)
FDA (11618)
Job Trends (10494)
News (258780)
Policy (27855)
Tag
Academia (2135)
Accelerated approval (8)
Adcomms (28)
Allergies (89)
Alliances (45821)
ALS (95)
Alzheimer's disease (1373)
Antibody-drug conjugate (ADC) (159)
Approvals (11590)
Artificial intelligence (240)
Autoimmune disease (28)
Automation (11)
Bankruptcy (266)
Best Places to Work (8794)
BIOSECURE Act (17)
Biosimilars (96)
Biotechnology (253)
Bladder cancer (85)
Brain cancer (34)
Breast cancer (305)
Cancer (2488)
Cardiovascular disease (192)
Career advice (1171)
Career pathing (20)
CAR-T (177)
CDC (34)
Cell therapy (458)
Cervical cancer (21)
Clinical research (59595)
Collaboration (915)
Company closure (2)
Compensation (581)
Complete response letters (27)
COVID-19 (2603)
CRISPR (62)
C-suite (244)
Cystic fibrosis (105)
Data (2564)
Decentralized trials (1)
Denatured (15)
Depression (53)
Diabetes (293)
Diagnostics (4139)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (37)
Drug discovery (121)
Drug pricing (125)
Drug shortages (31)
Duchenne muscular dystrophy (121)
Earnings (52234)
Editorial (43)
Employer branding (14)
Employer resources (107)
Events (72659)
Executive appointments (646)
FDA (12948)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (779)
Gene editing (131)
Generative AI (17)
Gene therapy (363)
GLP-1 (785)
Government (4334)
Grass and pollen (5)
Guidances (151)
Healthcare (13689)
Huntington's disease (29)
IgA nephropathy (36)
Immunology and inflammation (145)
Immuno-oncology (3)
Indications (35)
Infectious disease (2770)
Inflammatory bowel disease (138)
Inflation Reduction Act (11)
Influenza (60)
Intellectual property (102)
Interviews (241)
IPO (12759)
IRA (47)
Job creations (2111)
Job search strategy (1005)
Kidney cancer (10)
Labor market (26)
Layoffs (392)
Leadership (13)
Legal (7302)
Liver cancer (64)
Lung cancer (356)
Lymphoma (174)
Machine learning (9)
Management (35)
Manufacturing (314)
MASH (88)
Medical device (7321)
Medtech (7323)
Mergers & acquisitions (15463)
Metabolic disorders (786)
Multiple sclerosis (87)
NASH (22)
Neurodegenerative disease (113)
Neuropsychiatric disorders (35)
Neuroscience (1996)
NextGen: Class of 2025 (4523)
Non-profit (3115)
Now hiring (26)
Obesity (419)
Opinion (227)
Ovarian cancer (88)
Pain (82)
Pancreatic cancer (97)
Parkinson's disease (173)
Partnered (16)
Patents (243)
Patient recruitment (120)
Peanut (48)
People (38668)
Pharmaceutical (58)
Pharmacy benefit managers (15)
Phase I (18983)
Phase II (26406)
Phase III (19576)
Pipeline (1449)
Policy (194)
Postmarket research (2034)
Preclinical (8132)
Press Release (44)
Prostate cancer (119)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (439)
Real estate (3275)
Recruiting (49)
Regulatory (18478)
Reports (28)
Research institute (1916)
Resumes & cover letters (206)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (85)
Series A (134)
Series B (88)
Service/supplier (4)
Sickle cell disease (60)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (25)
Startups (2740)
State (1)
Stomach cancer (12)
Supply chain (65)
Tariffs (48)
The Weekly (62)
Vaccines (818)
Venture capital (44)
Weight loss (278)
Women's health (24)
Worklife (12)
Date
Today (108)
Last 7 days (472)
Last 30 days (2214)
Last 365 days (26684)
2025 (13042)
2024 (29548)
2023 (32866)
2022 (42104)
2021 (45098)
2020 (41714)
2019 (33750)
2018 (25326)
2017 (24806)
2016 (23021)
2015 (26825)
2014 (20473)
2013 (16335)
2012 (17008)
2011 (17646)
2010 (16406)
Location
Africa (607)
Alabama (56)
Alaska (5)
Arizona (133)
Arkansas (8)
Asia (31251)
Australia (5530)
California (5980)
Canada (1838)
China (581)
Colorado (236)
Connecticut (255)
Delaware (164)
Europe (73330)
Florida (842)
Georgia (202)
Hawaii (1)
Idaho (36)
Illinois (452)
India (26)
Indiana (256)
Iowa (15)
Japan (179)
Kansas (84)
Kentucky (20)
Louisiana (13)
Maine (34)
Maryland (882)
Massachusetts (4600)
Michigan (144)
Minnesota (259)
Mississippi (2)
Missouri (60)
Montana (24)
Nebraska (11)
Nevada (59)
New Hampshire (30)
New Jersey (1706)
New Mexico (19)
New York (1681)
North Carolina (823)
North Dakota (7)
Northern California (2668)
Ohio (169)
Oklahoma (11)
Oregon (25)
Pennsylvania (1187)
Puerto Rico (12)
Rhode Island (25)
South America (848)
South Carolina (19)
South Dakota (1)
Southern California (2243)
Tennessee (69)
Texas (775)
United States (21534)
Utah (126)
Virginia (153)
Washington D.C. (54)
Washington State (483)
West Virginia (3)
Wisconsin (46)
501,312 Results for "affimed therapeutics ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting
April 24, 2025
·
2 min read
Press Releases
Memo Therapeutics AG Publishes Study in Frontiers in Pharmacology Demonstrating Therapeutic Antibody Transcytosis Across the Kidney Barrier After Intravenous Administration
June 12, 2025
·
2 min read
Press Releases
Affimed to Present at the Leerink Partners Global Healthcare Conference 2025
March 4, 2025
·
1 min read
Opinion
Bringing Neurological Disease Into the Age of Precision Medicine
To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of protein aggregates in the brain.
May 12, 2025
·
5 min read
·
John McDonough
Press Releases
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
June 18, 2025
·
5 min read
Press Releases
HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
May 8, 2025
·
5 min read
Press Releases
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
April 30, 2025
·
4 min read
Press Releases
Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting
March 25, 2025
·
2 min read
Press Releases
Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
June 11, 2025
·
3 min read
Business
Affimed Reports First Quarter 2024 Financial Results & Business Update
Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported financial results and provided an update on clinical and corporate progress for the quarter ended March 31, 2024.
June 12, 2024
·
15 min read
1 of 50,132
Next
